Perhaps the fact that they have approved Adequan in the US has meant the merits of PPS in treating OA hasn't been well publicised or understood by vets. Where PPS is approved for veterinary use it's a completely different matter
MOZZ Research - First Half 2021, page-38
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
25.0¢ |
Change
0.015(6.38%) |
Mkt cap ! $87.44M | |||
| Open | High | Low | Value | Volume |
| 24.0¢ | 25.0¢ | 23.0¢ | $95.91K | 396.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 117676 | 24.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 25.0¢ | 36524 | 4 |
View Market Depth
| Last trade - 16.10pm 10/09/2024 (20 minute delay) ? |
| PAR (ASX) Chart |